Cancer Patients Are Overmedicated To Enrich Health Systems

Are patients being prescribed more medications not for their health, but to generate profit? A new economic study published in The Journal of Health Economics reveals that cancer patients treated by physicians participating in the 340B Program receive more medications—including those outside clinical guidelines—without improvements in survival.

The federal program, named after Section 340B of the Public…